Company Analysis

Telomir Pharmaceuticals, Inc. (TELO)

Nasdaq: TELO · Pharmaceutical Preparations · Miami, FL · filing with the SEC since 2023
Grade4.5
◀ Past 5.2● Present 3.6▶ Future 5.0
7 est.

Filings

115 filings since 2017 beside 35 insider forms · Non-accelerated filer and smaller reporting company and emerging growth company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company and emerging growth company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Jul 28, 2026.

Filings a yearinsider forms included
13474941
2023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 8 times in the last 36 months, the newest Jun 8, 2026.Listing warning from its exchange (8-K item 3.01): 1 time in the last 36 months, the newest Jan 12, 2026.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest Dec 20, 2024.SEC letters: 9 in the last 36 months, the newest Feb 26, 2025.
Insider forms 35

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 6, 2026 10-Q Quarterly report Sep 30, 2026
Nov 5, 2026 EFFECT Registration effective
Nov 5, 2026 424B3 Shelf offering
Oct 27, 2026 S-3 Shelf registration
Oct 6, 2026 8-K items 1.01, 3.02, 7.01, 9.01 Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD) · Current report Oct 5, 2026
Sep 17, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Sep 16, 2026 8-K items 5.07, 9.01 Shareholder vote · Current report Sep 11, 2026
Sep 14, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Aug 19, 2026 DEFA14A Extra proxy material
Aug 14, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 13, 2026 10-Q Quarterly report Jun 30, 2026
Aug 10, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Jul 28, 2026 DEF 14A Proxy statement
Jun 15, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Jun 8, 2026 8-K items 5.02, 9.01 Officer or director change · Current report Jun 3, 2026
May 20, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
May 14, 2026 10-Q Quarterly report Mar 31, 2026
Apr 30, 2026 8-K item 8.01 Other event · Current report Apr 24, 2026
Apr 24, 2026 8-K items 1.01, 2.01, 3.02, 9.01 Major agreement signed; Purchase or sale of a business completed; Shares sold without registration · Current report Apr 22, 2026
Mar 31, 2026 8-K item 8.01 Other event · Current report Mar 30, 2026
Mar 31, 2026 8-K item 8.01 Other event · Current report
Mar 27, 2026 8-K items 5.02, 5.03, 5.07, 9.01 Officer or director change; Charter, bylaw or fiscal-year change; Shareholder vote · Current report Mar 23, 2026
Mar 17, 2026 10-K Annual report Dec 31, 2025
Feb 19, 2026 DEFM14A Merger proxy statement
Feb 19, 2026 DEFA14A Extra proxy material
Feb 17, 2026 8-K item 8.01 Other event · Current report
Feb 12, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 5, 2026 8-K item 8.01 Other event · Current report
Feb 5, 2026 PRER14A Form PRER14A
Jan 23, 2026 PRER14A Form PRER14A
Jan 12, 2026 8-K item 3.01 Listing warning from its exchange · Current report Jan 8, 2026
Jan 5, 2026 8-K item 8.01 Other event · Current report
Dec 22, 2025 8-K item 5.02 Officer or director change · Current report Dec 17, 2025
Dec 17, 2025 8-K item 8.01 Other event · Current report
Nov 28, 2025 PRER14A Form PRER14A
Nov 24, 2025 8-K item 8.01 Other event · Current report
Nov 20, 2025 8-K items 5.02, 9.01 Officer or director change · Current report Nov 14, 2025
Nov 20, 2025 PREM14A Preliminary merger proxy
Nov 20, 2025 8-K item 8.01 Other event · Current report
Nov 12, 2025 8-K item 8.01 Other event · Current report
40 of 115 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton TELO · research, not advice